GSK Expands US Biopharma Presence with 2.2 Billion USD Food Allergy Acquisition
Analysis India: The GSK US biopharma acquisition of RAPT Therapeutics is more than just a major corporate deal. This GSK US biopharma acquisition reflects a clear strategy by GSK to strengthen its long term position in the United States biopharma market. By completing this GSK US biopharma acquisition, the company is securing a clinical stage […]
GSK Expands US Biopharma Presence with 2.2 Billion USD Food Allergy Acquisition Read More »





